Supplementary data-Intra-vaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. 2018.pdf (68.26 kB)

Supplementary data-Intra-vaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors. 2018.pdf

Download (68.26 kB)
dataset
posted on 04.08.2018, 03:08 by Susan DavisSusan Davis
This table reports the clinician reported assessment outcomes for intra-vaginal testosterone vs placebo over 26 weeks in women taking an aromatase inhibitor

Funding

Accelerator Grant of the National Breast Cancer Foundation (Australia) Grant no: NT-16-006

History

Usage metrics

Categories

Licence

Exports